 - Medications or supplements that are known to be strong CYP3A mechanism-based inhibitors or strong CYP3A inducers andor P-gp inducers within 7 days, or within 5 times the inhibitor or inducer half-life whichever is longer, before the first dose of study drug. The use of these agents is not permitted during the study. 